News Image

Analyzing NASDAQ:GILD's Dividend Potential.

By Mill Chart

Last update: Mar 26, 2024

GILEAD SCIENCES INC (NASDAQ:GILD) has caught the attention of dividend investors as a stock worth considering. NASDAQ:GILD excels in profitability, solvency, and liquidity, all while providing a decent dividend. Let's delve into the details.

Dividend Analysis for NASDAQ:GILD

ChartMill assigns a Dividend Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing various dividend elements, such as yield, historical performance, dividend growth, and sustainability. NASDAQ:GILD has been awarded a 7 for its dividend quality:

  • GILD has a Yearly Dividend Yield of 4.21%, which is a nice return.
  • Compared to an average industry Dividend Yield of 164.55, GILD pays a better dividend. On top of this GILD pays more dividend than 98.98% of the companies listed in the same industry.
  • GILD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
  • GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As GILD did not decrease their dividend in the past 5 years, we can say the dividend looks stable.

Health Insights: NASDAQ:GILD

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 5 out of 10:

  • With a decent Altman-Z score value of 2.68, GILD is doing good in the industry, outperforming 71.26% of the companies in the same industry.
  • GILD has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as GILD would need 3.37 years to pay back of all of its debts.
  • GILD's Debt to FCF ratio of 3.37 is amongst the best of the industry. GILD outperforms 95.24% of its industry peers.

Profitability Insights: NASDAQ:GILD

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 7 out of 10:

  • GILD's Return On Assets of 9.12% is amongst the best of the industry. GILD outperforms 97.11% of its industry peers.
  • With an excellent Return On Equity value of 24.81%, GILD belongs to the best of the industry, outperforming 98.13% of the companies in the same industry.
  • GILD has a Return On Invested Capital of 12.07%. This is amongst the best in the industry. GILD outperforms 97.28% of its industry peers.
  • The Profit Margin of GILD (20.89%) is better than 97.62% of its industry peers.
  • GILD has a Operating Margin of 28.23%. This is amongst the best in the industry. GILD outperforms 98.13% of its industry peers.
  • GILD's Gross Margin of 76.04% is amongst the best of the industry. GILD outperforms 85.54% of its industry peers.

More Best Dividend stocks can be found in our Best Dividend screener.

Our latest full fundamental report of GILD contains the most current fundamental analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (4/18/2024, 7:00:02 PM)

After market: 66.22 +0.06 (+0.09%)

66.16

-0.77 (-1.15%)

GILD News

News Image13 hours ago - Zacks Investment ResearchGilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.

News Image21 hours ago - Zacks Investment ResearchAnalysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for

Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image2 days ago - ChartmillWhy the dividend investor may take a look at NASDAQ:GILD.

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

News Image4 days ago - Market News VideoKKR Moves Up In Market Cap Rank, Passing Gilead Sciences
News Image4 days ago - The Motley FoolBetter Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

News Image4 days ago - The Motley FoolShould You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Dividend stocks can be a smart way to ride out market volatility.

News Image8 days ago - Market News VideoGILD May 31st Options Begin Trading
News Image8 days ago - FinancialNewsMediaBiotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

News Image8 days ago - USA News GroupBiotech Innovations Paving the Way in Breast Cancer Fight

/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...

News Image10 days ago - InvestorPlace3 Stocks at 52-Week Lows Poised for a Powerful Rebound

Starbucks, Gilead, and Vale are three stocks at 52-week lows that show signs of recovery potential and long-term growth prospects.

News Image11 days ago - Market News VideoRelative Strength Alert For Gilead Sciences
News Image11 days ago - Gilead Sciences, Inc.Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
GILD Links
Follow us for more